$2T isn’t locked up in ANT - you’re confusing market cap with actual capital. For what it’s worth ANT total external infusion is ~250B not 2T.
Now they are established they can get much more capital anyway. The question is - can they actually meaningfully use even these 250B?
Now they are established they can get much more capital anyway. The question is - can they actually meaningfully use even these 250B?